Catheter-Based Tx Disappoints for Deep Vein Thrombosis Thrombolytic tx didn't cut post-thrombotic syndrome in trial
WASHINGTON — Anticoagulants alone remained the best course of therapy for deep vein thrombosis (DVT) — though patients with iliofemoral disease showed a signal of benefit from pharmacomechanical catheter-directed thrombolysis (PCDT), according to the ATTRACT randomized trial.